From: Optimal use of lenvatinib in the treatment of advanced thyroid cancer
Hypertension
Diarrhea
Fatigue
PPE
Proteinuria
Thrombocytopenia
Phase III (general population) (n = 261) [2]
Any grade
68
59
32
31
9
Grade ≥ 3
42
8
3
10
2
Phase III (Japanese population) (n = 30) [7]
87
60
70
63
47
80
0
13
20
7